InMode INMD
$12.42 −$0.28 (-2.20%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $12.32 -0.81%
Open$12.64
Prev close$12.70
Day range$12.40 – $12.69
Volume707.6K
Market cap$714.70M
P/E (TTM)10.4
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$92.14M-1.1% YoY
Operating profit$17.51M-16.2% YoY
Net profit$18.86M-13.7% YoY
Diluted EPS$0.32-5.9% YoY
Free cash flow$11.19M-54.0% YoY
Operating cash flow$11.38M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin76.6%
Operating margin17.6%
Net margin19.9%
Return on equity11.4%
Return on assets10.1%
Return on invested capital11.3%
Current ratio8.58
Liabilities / assets12.1%
Cash & investments$512.73M
Total debt$3.58M
Net cash (debt)$509.15M
Free cash flow / sales18.6%
Where the revenue comes from
Quarter 2026/Q1
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $92.14M | $95.59M | $82.02M | $370.50M | $103.85M |
| Total Operating Revenue | $92.14M | $95.59M | $82.02M | $370.50M | $103.85M |
| Cost of Revenue | $20.34M | $24.07M | $20.47M | $79.53M | $22.55M |
| Gross Profit | $71.79M | $71.52M | $61.55M | $290.97M | $81.30M |
| Operating Expense | $54.29M | $59.26M | $51.50M | $205.58M | $55.31M |
| Selling and Admin Expenses | $50.42M | $55.60M | $47.95M | $192.26M | $51.80M |
| -Selling & Marketing Expense | $45.95M | $50.82M | $42.93M | $180.58M | $48.41M |
| -General & Admin Expense | $4.47M | $4.79M | $5.02M | $11.69M | $3.39M |
| Research & Development | $3.86M | $3.66M | $3.54M | $13.32M | $3.51M |
| Operating Profit | $17.51M | $12.26M | $10.06M | $85.39M | $25.99M |
| Net Non-Operating Interest Income (Expense) | $4.71M | $7.43M | $4.30M | $24.94M | $5.30M |
| Total Other Finance Costs | -$4.71M | -$7.43M | – | – | – |
| Pretax Profit | $22.22M | $19.69M | $14.35M | $110.33M | $31.29M |
| Tax | $3.36M | $2.63M | $2.79M | $16.50M | $4.27M |
| Net Profit | $18.86M | $17.06M | $11.56M | $93.83M | $27.03M |
| Profit from Continuing Operations | $18.86M | $17.06M | $11.56M | $93.83M | $27.03M |
| Net Income to Parent Company | $18.86M | $17.06M | $11.56M | $93.83M | $27.03M |
| Net Income to Common Stockholders | $18.86M | $17.06M | $11.56M | $93.83M | $27.03M |
| Basic EPS | $0.33 | $0.29 | $0.18 | $1.45 | $0.43 |
| Diluted EPS | $0.32 | $0.29 | $0.18 | $1.43 | $0.42 |
| Non-Operating Interest Income | – | – | $4.30M | $24.94M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $740.48M | $720.33M | $750.84M | $766.43M | $766.43M |
| Total Current Assets | $670.80M | $650.00M | $680.78M | $698.62M | $698.62M |
| Cash and Cash Equivalents & Short-Term Investments | $512.73M | $501.12M | $537.16M | $555.33M | $555.33M |
| -Cash and Cash Equivalents | $397.11M | $396.17M | $394.30M | $302.54M | $302.54M |
| -Short Term Investments | $115.62M | $104.94M | $142.86M | $252.79M | $252.79M |
| Receivables | $85.66M | $77.22M | $72.21M | $49.28M | $49.28M |
| -Accounts Receivable | $49.96M | $44.56M | $40.70M | $43.50M | $43.50M |
| -Other Receivables | $35.71M | $32.66M | $31.51M | $1.83M | $1.83M |
| Inventory | $72.42M | $71.66M | $71.41M | $74.05M | $74.05M |
| Total Non-Current Assets | $69.67M | $70.34M | $70.06M | $67.81M | $67.81M |
| Net PPE | $10.77M | $11.32M | $11.23M | $10.87M | $10.87M |
| -Gross PPE | $10.77M | $11.32M | $11.23M | $15.75M | $15.75M |
| Investments and Advances | $700,000.00 | $700,000.00 | $700,000.00 | $700,000.00 | $700,000.00 |
| Non Current Accounts Receivables | $6.12M | $5.69M | $5.21M | $3.01M | $3.01M |
| Non-Current Deferred Assets | $52.08M | $52.63M | $52.92M | $53.23M | $53.23M |
| Total Liabilities | $89.26M | $91.20M | $89.58M | $83.23M | $83.23M |
| Total Current Liabilities | $78.18M | $79.44M | $77.35M | $70.74M | $70.74M |
| Payables | $17.91M | $18.79M | $16.85M | $18.67M | $18.67M |
| -Accounts Payable | $17.91M | $18.79M | $16.85M | $17.91M | $17.91M |
| Current Deferred Liabilities | $15.25M | $15.45M | $16.37M | $12.09M | $12.09M |
| Other Current Liabilities | $45.03M | $45.19M | $44.13M | $15.96M | $15.96M |
| Total Non-Current Liabilities | $11.08M | $11.76M | $12.23M | $12.49M | $12.49M |
| Long Term Debt and Capital Lease Obligation | $3.58M | $4.45M | $4.83M | $5.01M | $5.01M |
| -Long Term Capital Lease Obligation | $3.58M | $4.45M | $4.83M | $5.01M | $5.01M |
| Non-Current Deferred Liabilities | $2.50M | $2.48M | $2.75M | $3.04M | $3.04M |
| Other Non-Current Liabilities | $5.00M | $4.83M | $4.66M | $4.44M | $4.44M |
| Total Equity | $651.22M | $629.13M | $661.25M | $683.20M | $683.20M |
| Stockholders' Equity | $651.22M | $629.13M | $661.25M | $683.20M | $683.20M |
| -Taxes Receivable | – | – | – | $3.95M | $3.95M |
| Prepaid Assets | – | – | – | $19.96M | $19.96M |
| -Accumulated Depreciation | – | – | – | -$4.88M | -$4.88M |
| -Long Term Equity Investment | – | – | – | $700,000.00 | $700,000.00 |
| -Total Tax Payable | – | – | – | $761,000.00 | $761,000.00 |
| Current Accrued Expenses | – | – | – | $1.71M | $1.71M |
| Short-Term Debt and Capital Lease Obligation | – | – | – | $3.22M | $3.22M |
| -Current Capital Lease Obligation | – | – | – | $3.22M | $3.22M |
| Current Provisions | – | – | – | $931,000.00 | $931,000.00 |
| Capital Stock | – | – | – | $251,000.00 | $251,000.00 |
| -Common Stock | – | – | – | $251,000.00 | $251,000.00 |
| Additional Paid-In Capital | – | – | – | $209.62M | $209.62M |
| Retained Earnings | – | – | – | $968.53M | $968.53M |
| Less: Treasury Stock | – | – | – | -$495.27M | -$495.27M |
| Gains/Losses Not Affecting Retained Earnings | – | – | – | $69,000.00 | $69,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $11.38M | $21.05M | $15.39M | $85.26M | $22.67M |
| Net cash flow from continuing operations | $11.38M | $21.05M | $15.39M | $85.26M | $22.67M |
| Net Income from Continuing Operations | $18.86M | $17.06M | $11.56M | $93.83M | $27.03M |
| Depreciation & Depletion & Amortization | $232,000.00 | $179,000.00 | $175,000.00 | $695,000.00 | $174,000.00 |
| Deferred Tax | $554,000.00 | $295,000.00 | $327,000.00 | $2.93M | $864,000.00 |
| Other Non-Cash Items | -$890,000.00 | $388,000.00 | $719,000.00 | $498,000.00 | -$762,000.00 |
| Change in Working Capital | -$11.10M | -$1.30M | -$621,000.00 | -$24.30M | -$7.42M |
| -Change in Receivables | -$9.46M | -$6.21M | -$5.79M | -$11.13M | -$7.63M |
| -Change in Inventory | -$754,000.00 | -$253,000.00 | $2.64M | -$14.50M | -$2.65M |
| -Change in Payables and Accrued Expense | -$887,000.00 | $1.94M | -$1.06M | $4.13M | $1.19M |
| -Change in Other Current Liabilities | $189,000.00 | $4.40M | -$388,000.00 | $2.16M | $4.76M |
| -Change In Other Working Capital | -$187,000.00 | -$1.18M | $3.98M | -$4.96M | -$3.09M |
| Net cash flow from investing | -$10.75M | $37.68M | $109.10M | $186.03M | $27.22M |
| Net Cash Flow from Continuing Investing Activities | -$10.75M | $37.68M | $109.10M | $186.03M | $27.22M |
| Net PPE Purchase and Sale | -$195,000.00 | -$211,000.00 | -$172,000.00 | -$972,000.00 | -$534,000.00 |
| Net Investment Purchase and Sale | -$10.56M | $37.90M | $109.28M | $187.00M | $27.76M |
| Financing Cash Flow | $97,000.00 | -$56.49M | -$32.43M | -$126.06M | $137,000.00 |
| Net Cash Flow from Continuing Financing Activities | $97,000.00 | -$56.49M | -$32.43M | -$126.06M | $137,000.00 |
| Net Common Stock Issuance | $0.00 | -$56.51M | -$31.24M | -$127.44M | $0.00 |
| Proceeds from Stock Option Exercised | $97,000.00 | $19,000.00 | $617,000.00 | $1.39M | $137,000.00 |
| Ending Cash Balance | $397.11M | $396.17M | $394.30M | $302.54M | $302.54M |
| Net Change in Cash | $731,000.00 | $2.24M | $92.06M | $145.23M | $50.03M |
| Beginning Cash Balance | $396.17M | $394.30M | $302.54M | $155.33M | $252.44M |
| Effect of Exchange Rate Changes | $207,000.00 | -$365,000.00 | -$311,000.00 | $1.98M | $72,000.00 |
| Free Cash Flow | $11.19M | $20.84M | $15.21M | $84.29M | $22.14M |
| Net Other Financing Charges | – | – | -$1.80M | – | – |
| Gain/Loss from Continuing Operations | – | – | – | $15,000.00 | $1,000.00 |
No comments yet — be the first to weigh in on INMD.
Sign in to join the discussion.